天域生物
(603717)
| 流通市值：21.09亿 | | | 总市值：21.09亿 |
| 流通股本：2.90亿 | | | 总股本：2.90亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 154,661,388.37 | 178,048,527.26 | 161,294,801.64 | 179,590,104.57 |
| 应收票据及应收账款 | 316,173,186.86 | 396,929,321.24 | 348,937,991.5 | 356,405,873.51 |
| 其中：应收票据 | 270,000 | 5,700,000 | 48,800 | 1,048,800 |
| 应收账款 | 315,903,186.86 | 391,229,321.24 | 348,889,191.5 | 355,357,073.51 |
| 应收款项融资 | - | - | 3,529,563.06 | - |
| 预付款项 | 33,129,878.71 | 17,853,478.61 | 43,128,070.99 | 65,761,337.1 |
| 其他应收款合计 | 175,219,225.28 | 167,753,324.2 | 173,240,684.17 | 179,029,562.6 |
| 存货 | 202,900,702.9 | 223,765,533.14 | 230,337,207.94 | 221,840,665.18 |
| 合同资产 | 314,773,098.75 | 338,958,630.51 | 418,572,849.08 | 405,858,961.69 |
| 一年内到期的非流动资产 | 82,487,516.27 | 82,487,516.27 | 81,902,989.89 | 109,570,698.14 |
| 其他流动资产 | 51,970,035.73 | 46,997,969.19 | 43,909,323.67 | 42,962,351.7 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,331,315,032.87 | 1,452,794,300.42 | 1,508,881,641.94 | 1,561,019,554.49 |
| 非流动资产: | | | | |
| 长期应收款 | 366,604,358.56 | 375,960,874.8 | 409,427,117.62 | 419,075,203.73 |
| 长期股权投资 | 88,004,733.72 | 86,004,733.72 | 83,546,974.91 | 83,546,974.91 |
| 其他非流动金融资产 | 11,495,191.88 | 11,495,191.88 | 11,495,191.88 | 11,495,191.88 |
| 投资性房地产 | 3,447,743.07 | 3,553,682.84 | 3,659,622.57 | 3,765,562.34 |
| 固定资产 | 330,264,220.87 | 337,289,989.64 | 344,743,955.13 | 333,336,431.56 |
| 在建工程 | 23,813,332.98 | 21,371,625.26 | 19,329,864.91 | 30,238,321.22 |
| 生产性生物资产 | 28,871,986.27 | 22,811,318.92 | 19,386,952.61 | 20,960,799.69 |
| 使用权资产 | 113,111,355.95 | 152,085,852 | 158,272,674.58 | 164,795,022.17 |
| 无形资产 | 25,899,915.63 | 26,153,778.05 | 26,386,221.62 | 26,704,865.66 |
| 商誉 | 2,082,182.88 | 2,082,182.88 | 7,207,726.18 | 7,207,726.18 |
| 长期待摊费用 | 4,720,787.73 | 4,947,132.61 | 4,967,120.02 | 5,097,432.54 |
| 递延所得税资产 | 105,163,014.09 | 105,400,561.05 | 105,184,249.52 | 107,818,589.42 |
| 其他非流动资产 | 618,561,981.17 | 613,033,064.02 | 572,790,876.82 | 534,519,372.3 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,722,040,804.8 | 1,762,189,987.67 | 1,766,398,548.37 | 1,748,561,493.6 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,053,355,837.67 | 3,214,984,288.09 | 3,275,280,190.31 | 3,309,581,048.09 |
| 流动负债: | | | | |
| 短期借款 | 66,577,437.38 | 88,932,107.34 | 87,282,963.19 | 155,465,473.17 |
| 应付票据及应付账款 | 589,132,797.93 | 638,329,893.72 | 605,402,221.43 | 633,254,651.19 |
| 其中：应付票据 | - | - | - | 3,000,000 |
| 应付账款 | 589,132,797.93 | 638,329,893.72 | 605,402,221.43 | 630,254,651.19 |
| 合同负债 | 119,742,340.48 | 144,647,669.46 | 109,799,237.43 | 86,731,023.47 |
| 应付职工薪酬 | 27,193,265.03 | 27,036,365.55 | 15,728,615.3 | 15,489,155.91 |
| 应交税费 | 1,586,466.62 | 1,125,280.3 | 1,479,713.54 | 579,507.85 |
| 其他应付款合计 | 154,097,830.54 | 166,845,822.82 | 101,582,059.44 | 107,125,194.62 |
| 应付股利 | 1,877,531.25 | 1,877,531.25 | 1,877,531.25 | 1,877,531.25 |
| 一年内到期的非流动负债 | 155,780,927.82 | 190,098,672.23 | 180,170,067.21 | 131,846,126.84 |
| 其他流动负债 | 66,948,538.17 | 89,332,338.91 | 78,936,282.86 | 73,537,247.94 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,181,059,603.97 | 1,346,348,150.33 | 1,180,381,160.4 | 1,204,028,380.99 |
| 非流动负债: | | | | |
| 长期借款 | 781,376,050.12 | 753,368,736.78 | 818,389,413.12 | 813,529,272.35 |
| 租赁负债 | 74,936,475.22 | 111,109,637.95 | 112,934,030.93 | 127,306,847.96 |
| 长期应付款 | 250,613,507.05 | 267,991,884.49 | 254,126,704.2 | 265,979,249.23 |
| 递延收益 | 668,537.33 | 688,796.03 | 709,054.73 | 729,313.43 |
| 递延所得税负债 | 2,619,644.11 | 2,682,283.17 | 2,728,619.12 | 2,849,804.06 |
| 其他非流动负债 | 26,453,796.76 | 24,262,552.79 | 26,903,646.74 | 27,634,061.4 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,136,668,010.59 | 1,160,103,891.21 | 1,215,791,468.84 | 1,238,028,548.43 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,317,727,614.56 | 2,506,452,041.54 | 2,396,172,629.24 | 2,442,056,929.42 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 290,146,240 | 290,146,240 | 290,146,240 | 290,146,240 |
| 资本公积 | 912,212,051.57 | 912,212,051.57 | 932,346,135.92 | 932,346,135.92 |
| 盈余公积 | 45,177,411.16 | 45,177,411.16 | 45,177,411.16 | 45,177,411.16 |
| 未分配利润 | -715,028,364.09 | -728,796,592.68 | -619,374,399.01 | -615,210,226.62 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 532,507,338.64 | 518,739,110.05 | 648,295,388.07 | 652,459,560.46 |
| 少数股东权益 | 203,120,884.47 | 189,793,136.5 | 230,812,173 | 215,064,558.21 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 735,628,223.11 | 708,532,246.55 | 879,107,561.07 | 867,524,118.67 |
| 负债和股东权益合计 | 3,053,355,837.67 | 3,214,984,288.09 | 3,275,280,190.31 | 3,309,581,048.09 |
| 公告日期 | 2025-04-30 | 2025-04-16 | 2024-10-31 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |